Pancreatitis Trial, Recruiting NCT05061680 Sponsor: Helsinki University Central Hospital Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT05061680
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are older than 18 years of age
  • You have a stone in your bile duct (the tube connecting your liver to your small intestine) that is larger than 10mm (about the size of a small pea)

Who may not be able to join:

  • Your digestive system has been restructured due to a previous surgery (such as a Billroth II or Roux-en-Y procedure) (confirm with trial site)
  • You have cysts (fluid-filled sacs) in your bile duct
  • You currently have acute pancreatitis (a sudden and severe inflammation of the pancreas)
  • You have a narrowing or tumour in the lower part of your bile duct
  • You have a condition that affects your blood's ability to clot properly
  • You are currently taking any medication that affects blood clotting (such as blood thinners)
  • You are pregnant
  • You are unable to give your own consent to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mia Rainio, Md, PhD, Helsinki University Central Hospital

Phone: +358505833060

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Helsinki University Central Hospital
Registry
ClinicalTrials.gov
Start date
5 April 2021
Est. completion
31 December 2025

Where this trial is recruiting

🇫🇮 Finland

Primary endpoints

Rate of bleeding; Rate of pancreatitis; Rate of cholangitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov